» Articles » PMID: 33778671

Q-Space Imaging Yields a Higher Effect Gradient to Assess Cellularity Than Conventional Diffusion-weighted Imaging Methods at 3.0 T: A Pilot Study with Freshly Excised Whole-Breast Tumors

Overview
Specialties Oncology
Radiology
Date 2021 Mar 29
PMID 33778671
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To determine whether q-space imaging (QSI), an advanced diffusion-weighted MRI method, provides a higher effect gradient to assess tumor cellularity than existing diffusion imaging methods, and fidelity to cellularity obtained from histologic analysis.

Materials And Methods: In this prospective study, diffusion-weighted images were acquired from 20 whole-breast tumors freshly excised from participants (age range, 35-78 years) by using a clinical 3.0-T MRI unit. Median and skewness values were extracted from the histogram distributions obtained from QSI, monoexponential model, diffusion kurtosis imaging (DKI), and stretched exponential model (SEM). The skewness from QSI and other diffusion models was compared by using paired tests and relative effect gradient obtained from correlating skewness values.

Results: The skewness obtained from QSI (mean, 1.34 ± 0.77 [standard deviation]) was significantly higher than the skewness from monoexponential fitting approach (mean, 1.09 ± 0.67; = .015), SEM (mean, 1.07 ± 0.70; = .014), and DKI (mean, 0.97 ± 0.63; = .004). QSI yielded a higher effect gradient in skewness (percentage increase) compared with monoexponential fitting approach (0.26 of 0.74; 35.1%), SEM (0.26 of 0.74; 35.1%), and DKI (0.37 of 0.63; 58.7%). The skewness and median from QSI were significantly correlated with the skewness (ρ = -0.468; = .038) and median (ρ = -0.513; = .021) of cellularity from histologic analysis.

Conclusion: QSI yields a higher effect gradient in assessing breast tumor cellularity than existing diffusion methods, and fidelity to underlying histologic structure. Breast, MR-Diffusion Weighted Imaging, MR-Imaging, Pathology, Tissue Characterization, Tumor ResponsePublished under a CC BY 4.0 license.

Citing Articles

Advanced breast diffusion-weighted imaging: what are the next steps? A proposal from the EUSOBI International Breast Diffusion-weighted Imaging working group.

Honda M, Sigmund E, Le Bihan D, Pinker K, Clauser P, Karampinos D Eur Radiol. 2024; .

PMID: 39379708 DOI: 10.1007/s00330-024-11010-0.


Spatial heterogeneity of peri-tumoural lipid composition in postmenopausal patients with oestrogen receptor positive breast cancer.

Cheung S, Chan K, Zhou W, Husain E, Gagliardi T, Masannat Y Sci Rep. 2024; 14(1):4699.

PMID: 38409583 PMC: 10897464. DOI: 10.1038/s41598-024-55458-y.


Towards detection of early response in neoadjuvant chemotherapy of breast cancer using Bayesian intravoxel incoherent motion.

Cheung S, Wu W, Senn N, Sharma R, McGoldrick T, Gagliardi T Front Oncol. 2023; 13:1277556.

PMID: 38125950 PMC: 10731248. DOI: 10.3389/fonc.2023.1277556.


Diffusion-time dependent diffusion MRI: effect of diffusion-time on microstructural mapping and prediction of prognostic features in breast cancer.

Ba R, Wang X, Zhang Z, Li Q, Sun Y, Zhang J Eur Radiol. 2023; 33(9):6226-6237.

PMID: 37071169 DOI: 10.1007/s00330-023-09623-y.

References
1.
Bailey C, Siow B, Panagiotaki E, Hipwell J, Mertzanidou T, Owen J . Microstructural models for diffusion MRI in breast cancer and surrounding stroma: an ex vivo study. NMR Biomed. 2016; 30(2). PMC: 5244665. DOI: 10.1002/nbm.3679. View

2.
Peintinger F, Sinn B, Hatzis C, Albarracin C, Downs-Kelly E, Morkowski J . Reproducibility of residual cancer burden for prognostic assessment of breast cancer after neoadjuvant chemotherapy. Mod Pathol. 2015; 28(7):913-20. PMC: 4830087. DOI: 10.1038/modpathol.2015.53. View

3.
King A, Chow K, Yu K, Mo F, Yeung D, Yuan J . Head and neck squamous cell carcinoma: diagnostic performance of diffusion-weighted MR imaging for the prediction of treatment response. Radiology. 2012; 266(2):531-8. DOI: 10.1148/radiol.12120167. View

4.
Corben A, Abi-Raad R, Popa I, Teo C, Macklin E, Koerner F . Pathologic response and long-term follow-up in breast cancer patients treated with neoadjuvant chemotherapy: a comparison between classifications and their practical application. Arch Pathol Lab Med. 2013; 137(8):1074-82. DOI: 10.5858/arpa.2012-0290-OA. View

5.
Sun K, Chen X, Chai W, Fei X, Fu C, Yan X . Breast Cancer: Diffusion Kurtosis MR Imaging-Diagnostic Accuracy and Correlation with Clinical-Pathologic Factors. Radiology. 2015; 277(1):46-55. DOI: 10.1148/radiol.15141625. View